TAM
Tocqueville Asset Management Portfolio holdings
AUM
$6.55B
1-Year Return
21.88%
This Quarter Return
+10.4%
1 Year Return
+21.88%
3 Year Return
+89.23%
5 Year Return
+153.22%
10 Year Return
+366.25%
AUM
$5.23B
AUM Growth
+$432M
(+9%)
Cap. Flow
-$88.2M
Cap. Flow
% of AUM
-1.69%
Top 10 Holdings %
Top 10 Hldgs %
25.64%
Holding
696
New
42
Increased
171
Reduced
285
Closed
47
Top Buys
| 1 |
Charles Schwab
SCHW
|
$19.2M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$17.2M |
| 3 |
Elanco Animal Health
ELAN
|
$16.4M |
| 4 |
Newmont
NEM
|
$12.7M |
| 5 |
Donaldson
DCI
|
$11.2M |
Top Sells
| 1 |
Apple
AAPL
|
$13.7M |
| 2 |
NVIDIA
NVDA
|
$11.5M |
| 3 |
Las Vegas Sands
LVS
|
$9.7M |
| 4 |
Bank of New York Mellon
BK
|
$9.09M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
$8.36M |
Sector Composition
| 1 | Technology | 18.66% |
| 2 | Consumer Discretionary | 17.3% |
| 3 | Healthcare | 12.3% |
| 4 | Industrials | 9.06% |
| 5 | Financials | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Canadian National Railway
CNI
$60.3B
| $234K | ﹤0.01% |
+2,200
| New | +$234K |
|
552
iShares Silver Trust
SLV
$20.1B
| $225K | ﹤0.01% |
+10,400
| New | +$225K |
|
|
XLRN
553
DELISTED
Acceleron Pharma Inc.
XLRN
| $225K | ﹤0.01% |
+2,000
| New | +$225K |
|
554
Corpay
CPAY
$22.4B
| $224K | ﹤0.01% |
940
-7,340
| -89% | -$1.75M |
|
555
The Mosaic Company
MOS
$10.3B
| $220K | ﹤0.01% |
12,050
-4,500
| -27% | -$82.2K |
|
556
Rio Tinto
RIO
$104B
| $218K | ﹤0.01% |
3,618
-32
| -0.9% | -$1.93K |
|
|
TDF
557
Templeton Dragon Fund
TDF
$283M
| $218K | ﹤0.01% |
9,925
| – | – |
|
558
Blackrock
BLK
$170B
| $217K | ﹤0.01% |
385
-50
| -11% | -$28.2K |
|
559
SPDR S&P MidCap 400 ETF Trust
MDY
$24B
| $215K | ﹤0.01% |
635
-280
| -31% | -$94.8K |
|
560
FMC
FMC
$4.72B
| $214K | ﹤0.01% |
2,020
-2,605
| -56% | -$276K |
|
561
LyondellBasell Industries
LYB
$17.7B
| $214K | ﹤0.01% |
3,039
-14
| -0.5% | -$986 |
|
562
Darling Ingredients
DAR
$5.07B
| $212K | ﹤0.01% |
+5,872
| New | +$212K |
|
563
Conagra Brands
CAG
$9.23B
| $211K | ﹤0.01% |
5,900
-496
| -8% | -$17.7K |
|
564
Ryder
R
$7.64B
| $211K | ﹤0.01% |
+5,000
| New | +$211K |
|
565
Brookfield Infrastructure Partners
BIP
$14.1B
| $207K | ﹤0.01% |
+6,525
| New | +$207K |
|
566
Coterra Energy
CTRA
$18.3B
| $205K | ﹤0.01% |
+11,800
| New | +$205K |
|
567
The 3D Printing ETF
PRNT
$78.9M
| $205K | ﹤0.01% |
+8,560
| New | +$205K |
|
568
Trade Desk
TTD
$25.5B
| $205K | ﹤0.01% |
3,950
-1,900
| -32% | -$98.6K |
|
569
BioXcel Therapeutics
BTAI
$55.2M
| $204K | ﹤0.01% |
+294
| New | +$204K |
|
570
Truist Financial
TFC
$60B
| $203K | ﹤0.01% |
5,326
-138
| -3% | -$5.26K |
|
571
ProShares Short QQQ
PSQ
$508M
| $192K | ﹤0.01% |
+2,320
| New | +$192K |
|
572
Sprott Physical Gold and Silver Trust
CEF
$6.47B
| $187K | ﹤0.01% |
10,200
| – | – |
|
573
Amkor Technology
AMKR
$6.09B
| $178K | ﹤0.01% |
15,894
+5,627
| +55% | +$63K |
|
574
DHT Holdings
DHT
$2B
| $173K | ﹤0.01% |
+33,586
| New | +$173K |
|
|
NBSE
575
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $154K | ﹤0.01% |
+1,018
| New | +$154K |
|